Skip to content

Study on the optimization and curative effect evaluation of treatment of connective tissue disease associated interstitial lung disease by supplementing qi, nourishing yin and activating blood circulation

Study on the optimization and curative effect evaluation of treatment of connective tissue disease associated interstitial lung disease by supplementing qi, nourishing yin and activating blood circulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017158
Enrollment
Unknown
Registered
2018-07-14
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CTD-ILD

Interventions

Test group / Control group:Supplementing qi, nourishing yin and activating blood mixture /Placebo

Sponsors

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Conforming to the diagnostic standard of Western medicine CTD-ILD; 2. Conforming to the diagnostic standard of deficiency of Qi and Yin and blood stasis syndrome in TCM; 3. Aged 18-75 years old; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The temperature is above 37.3 degrees centigrade; 2. Pulmonary tuberculosis, bronchiectasis, pneumoconiosis, silicosis, bronchopulmonary carcinoma, allergic pulmonary infiltration, or other Pulmonary disease; 3. Severe cardiopulmonary insufficiency; 4. Combined with diabetes or cardiovascular, cerebrovascular, kidney, lung, hematopoietic system and other serious primary diseases; 5. Pregnant or preparing for pregnancy and breast-feeding women; 6. Blood routine white blood cell count > 11 * 10^9/L, neutrophil ratio > 75%; 7. Abnormal renal function and / or ALT exceed 1.5 times the upper limit of normal value; 8. The platelet count was less than 100 x 10^9/L. Coagulation time and fibrinogen were significantly abnormal or bleeding tendency; 9. Allergic people (allergic to more than 2 kinds of drugs or foods or allergic to the known ingredients of the drug); 10. Patients who are taking part in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;Blood gas analysis;Image score R;Dyspnea scale;Cough degree score;6 minute walk test;Health survey list (SF-36);

Secondary

MeasureTime frame
Baseline variation of wheezing and cough symptoms;The curative effect of TCM Syndrome;Curative effect;

Countries

China

Contacts

Public ContactQU Nini

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

qvnini@sina.com+86 13304007158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026